Admission Date:  [**2157-3-17**]              Discharge Date:   [**2157-3-27**]  Date of Birth:  [**2080-5-21**]             Sex:   M  Service: MEDICINE  Allergies: Patient recorded as having No Known Allergies to Drugs  Attending:[**First Name3 (LF) 4365**] Chief Complaint: Dyspnea   Major Surgical or Invasive Procedure: Intubation/extubation Central venous line placement and removal PICC line placement   History of Present Illness: Mr. [**Known lastname 12367**] is a 76M with a PMH s/f DM, ventricular ependymoma s/p craniotomy and resection [**2152**], subdural hematoma s/p evacuation in [**2152**], who presents with acute onset of shortness of breath, diaphoresis, and tachypnea at his nursing home.
Room air sats at the time were in the 70s.
On presentation to the ED, vital signs were: T=104.2, BP=159/72, HR=170, RR=30-40, 100% on a NRB.
Soon after his blood pressure decreased to 104/63.
Vitals at the time of sign-out were BP=97/49, HR=119, 99% on CMV with an FiO2 of 100%.
A head CT done in the ED showed stable bifrontal SDH with possible subacute component on left, unchanged in appearance from prior study, with stable post operative changes, in addition to  chronic ethmoid and left maxillary sinus disease.
Past Medical History: [**Month (only) **]-[**2152-3-27**] - L sided weakness, incontinence head CT [**5-/2152**] - large mass arising from the septum pellicidum and growing into the right lateral ventricle; intraventricular tumor synaptophysin pos, chromogranin neg [**2152-6-20**] - craniotomy, resection of mass c/b L hemiplegia D/C to [**Hospital **] Rehab [**2152-8-4**] - MS changes at [**Hospital1 **], repeat head CT showed new B hygromas and L subdural hemorrhage - was evacuated [**2152-8-5**].
DM Type 2   Social History: Lives at [**Hospital3 2558**].
Responds to pain only   Pertinent Results: Labs on admission: [**2157-3-17**] 11:00AM BLOOD WBC-10.5 RBC-4.79 Hgb-15.6 Hct-46.2 MCV-96 MCH-32.6* MCHC-33.8 RDW-13.2 Plt Ct-361# [**2157-3-17**] 11:00AM BLOOD PT-14.8* PTT-24.8 INR(PT)-1.3* [**2157-3-17**] 11:00AM BLOOD Glucose-363* UreaN-29* Creat-1.7* Na-149* K-4.1 Cl-109* HCO3-21* AnGap-23* [**2157-3-17**] 11:00AM BLOOD ALT-24 AST-28 LD(LDH)-259* AlkPhos-79 Amylase-28 TotBili-0.7 [**2157-3-17**] 02:17PM BLOOD CK(CPK)-192* [**2157-3-17**] 02:17PM BLOOD CK-MB-4 cTropnT-0.02* [**2157-3-17**] 09:02PM BLOOD CK-MB-4 cTropnT-<0.01 [**2157-3-18**] 04:45AM BLOOD CK-MB-3 cTropnT-<0.01 [**2157-3-17**] 11:00AM BLOOD Calcium-9.9 Phos-2.3* Mg-2.0 [**2157-3-17**] 11:00AM BLOOD Cortsol-87.8* [**2157-3-17**] 11:00AM BLOOD CRP-291.0* [**2157-3-17**] 03:32PM BLOOD Type-ART Rates-20/2 Tidal V-550 PEEP-5 FiO2-100 pO2-216* pCO2-38 pH-7.35 calTCO2-22 Base XS--3 AADO2-462 REQ O2-78 -ASSIST/CON Intubat-INTUBATED [**2157-3-17**] 11:02AM BLOOD Glucose-344* Lactate-7.4* Na-151* K-3.8 Cl-110 calHCO3-22 .
Labs on discharge: [**2157-3-27**] 07:50AM BLOOD WBC-4.5 RBC-3.40* Hgb-10.8* Hct-32.2* MCV-95 MCH-31.8 MCHC-33.5 RDW-13.6 Plt Ct-333 [**2157-3-27**] 07:50AM BLOOD Glucose-152* UreaN-9 Creat-1.0 Na-139 K-3.9 Cl-103 HCO3-29 AnGap-11 [**2157-3-27**] 07:50AM BLOOD Calcium-8.3* Phos-2.3* Mg-1.9 .
Microbiology: Blood culture, urine culture, sputum culture no growth to date .
EKG [**3-19**] Sinus rhythm.
Compared to the previous tracing earlier this date sinus rhythm is now present.
Imaging: CXR [**3-17**]: Hazy lingular opacity likely representing pneumonia versus aspiration.
CT head [**3-17**]: 1) Chronic bifrontal subdural collections with the left collection remaining slightly hyperdense compared to the right, unchanged in appearance from the prior study.
Brief Hospital Course: Mr. [**Known lastname 12367**] is a 76 year old nursing home resident who presented with a left lower lobe pneumonia who came to the ICU with hemodynamic instability, likely pneumosepsis, was intubated upon arrival, then extubated on [**3-23**], transferred to medical floor.
Upon extubation, speech and swallow evaluation was performed, which allowed for softs with 1:1 supervision, which patient tolerated.
Piperacillin-Tazobactam-Dextrs 4.5 gram/100 mL Piggyback Sig: One Hundred (100) mL Intravenous Q8H (every 8 hours) for 4 days: through [**3-30**].
